{"doi":"10.1182/blood.2022016930","title":"RBC, heal thyself: PK activators in SCD","abstract":null,"journal":"Blood","year":2022,"id":599940,"datarank":0.16479184330021646,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"self_citation_contribution":0.16479184330021646,"citation_network_contribution":0.0,"self_endowment_contribution":0.16479184330021646,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1425897,"name":"Jane A. Little","orcid":"0000-0001-6526-9674","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"RBC, heal thyself: PK activators in SCD","abstract":"In this issue of Blood, Xu et al 1 open the hood of the sickle hemoglobin (HbS)-containing red blood cells (RBCs) and cleverly soup up the carburetor; that is, they exploit endogenous metabolic pathways to improve RBC health in sickle cell disease (SCD) through activation of a distal enzyme in the glycolytic pathway, pyruvate kinase 2 (PK; see figure). The goal is to increase the oxygen affinity of HbS by decreasing the concentration of the allosteric effector 2,3-diphosphoglycerate (2,3-DPG).","is_dataset_classified":null,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"36355466","pmcid":null,"openalex_id":"https://openalex.org/W4308713833","authors":[],"funders":[],"total_grants":0,"fwci":0.1364,"citation_percentile":0.4858475,"influential_citations":0,"citation_trend":[{"year":2023,"count":1},{"year":2026,"count":1}],"oa_status":"bronze","license":null,"oa_locations":[{"url":"https://ashpublications.org/blood/article-pdf/140/19/2005/1929393/main.pdf","host_type":"journal"},{"url":"https://ashpublications.org/blood/article-pdf/140/19/2005/1929393/main.pdf","host_type":"publisher"},{"url":"https://doi.org/10.1182/blood.2022016930","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/36355466","host_type":"repository"}],"fields_of_study":["Hemoglobinopathies and Related Disorders","Erythrocyte Function and Pathophysiology","Metabolism, Diabetes, and Cancer"],"mesh_terms":["Anemia, Sickle Cell","Humans","Piperazines","Pyruvate Kinase","Quinolines","Pyruvic Acid"],"keywords":["Medicine","Internal medicine"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-29T11:44:22.869950Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}